{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:17:00Z","timestamp":1792088220549,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.autrev.2012.07.005","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T10:14:45Z","timestamp":1341656085000},"page":"114-120","source":"Crossref","is-referenced-by-count":99,"title":["Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Danilo","family":"Villalta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Imbastaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Lauriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gabini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Costanza","family":"Turi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.07.005_bb0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1521-6942(04)00042-7","article-title":"Scleroderma \u2014 clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.autrev.2011.02.005","article-title":"Systemic sclerosis. Introduction","volume":"10","author":"Chighizola","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.autrev.2010.09.017","article-title":"Immunogenetics of systemic sclerosis","volume":"10","author":"Dieud\u00e9","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","article-title":"Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy","volume":"10","author":"Wei","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","article-title":"Cellular players in angiogenesis during the course of systemic sclerosis","volume":"10","author":"Cipriani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2012.05.004","article-title":"Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases","author":"Fenoglio","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.1780230602","article-title":"Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome","volume":"23","author":"Tan","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0045","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N","article-title":"Prediction of five years survival following presentation with scleroderma: development of a simple model using three factors at first visit","volume":"42","author":"Bryan","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0050","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2008.06.010","article-title":"Predictive value of antinuclear autoantibodies: the lesson of the systemic sclerosis autoantibodies","volume":"7","author":"Koening","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/clinchem\/46.10.1681","article-title":"Sensitivity and specificity of immunological methods for the detection of anti-topoisomerase I (Scl70) autoantibodies: results of a multicenter study","volume":"46","author":"Bizzaro","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2012.07.005_bb0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.autrev.2010.09.025","article-title":"Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F","volume":"10","author":"Fritzler","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0065","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2009.02.018","article-title":"Anti-topoisomerase I autoantibodies in systemic sclerosis","volume":"8","author":"Cz\u00f6mp\u00f6ly","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","article-title":"Anti-fibrillarin antibodies in systemic sclerosis","volume":"40","author":"Tormey","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2012.07.005_bb0075","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspect of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0080","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0021-9258(18)32991-0","article-title":"Detection of a nucleolar 7\u20102 ribonucleoprotein and a cytoplasmic 8\u20102 ribonucleoprotein with autoantibodies from patients with scleroderma","volume":"258","author":"Reddy","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.07.005_bb0085","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1084\/jem.174.5.1239","article-title":"Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR and ribosomal transcription upstream binding factor","volume":"174","author":"Chan","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.07.005_bb0090","series-title":"Autoantibodies","first-page":"247","article-title":"Anti-RNA polymerase III autoantibodies","author":"Tozzoli","year":"2007"},{"key":"10.1016\/j.autrev.2012.07.005_bb0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1172\/JCI110295","article-title":"Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap","volume":"68","author":"Mimori","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.07.005_bb0100","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.07.005_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2007.02.020","article-title":"Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and pathway for novel therapeutic targets","volume":"7","author":"Gabrielli","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0110","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1002\/art.21232","article-title":"Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical association in systemic sclerosis","volume":"52","author":"Kuwana","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.autrev.2008.12.001","article-title":"PM1-alpha ELISA: the assay of choice from the detection of anti-PM\/Scl autoantibodies?","volume":"8","author":"Mahler","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cca.2010.01.037","article-title":"Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis","volume":"411","author":"Villalta","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2012.07.005_bb0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0130","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunological tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0145","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cca.2011.02.031","article-title":"Diagnostic assays for anti-PM\/Scl IgG antibodies: heterogeneity in antibody response or lack of standardization?","volume":"412","author":"Jaskowski","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2012.07.005_bb0150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.1994.03510290071040","article-title":"Users' guide to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid?","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2012.07.005_bb0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","article-title":"Users' guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2012.07.005_bb0160","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/ar3029","article-title":"Clinical and serological evaluation of a novel CENP-A peptide based ELISA","volume":"12","author":"Mahler","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.07.005_bb0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2010.06.005","article-title":"Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality?","volume":"9","author":"Mahler","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","article-title":"Clinical correlation and prognosis based on serum autoantibodies in patient with progressive systemic sclerosis","volume":"31","author":"Steen","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0175","first-page":"43","article-title":"Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis","volume":"48","author":"Bernstein","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0180","first-page":"80","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.07.005_bb0185","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.autrev.2009.02.002","article-title":"Anti-RNA polymerase III antibodies. A marker of systemic sclerosis with rapid onset and skin thickening progression","volume":"8","author":"Cavazzana","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0190","first-page":"1543","article-title":"Autoantibodies to NOR 90\/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response","volume":"29","author":"Dagher","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0195","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.07.005_bb0200","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2007.01.008","article-title":"Epidemiological and ethical aspect of multiplex autoantibody testing","volume":"6","author":"Bidoli","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0205","first-page":"104","article-title":"Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis","volume":"34","author":"Meyer","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0210","first-page":"301","article-title":"Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis","volume":"21","author":"Bardoni","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13317-011-0015-y","article-title":"Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients","volume":"2","author":"Morozzi","year":"2011","journal-title":"Autoimmun Highlights"},{"key":"10.1016\/j.autrev.2012.07.005_bb0220","first-page":"373","article-title":"Validation of a new immunoenzymatic method to detect antibodies to RNA polymerases III in systemic sclerosis","volume":"25","author":"Codullo","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0225","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.173.4.941","article-title":"Molecular characterization of an autoantigen of PM-Scl in the polymyositis\/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acid protein of the nucleolar complex","volume":"173","author":"Alderuccio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.07.005_bb0230","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.176.4.973","article-title":"Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome related nucleolar 100-kD protein","volume":"176","author":"Bl\u00fctner","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.07.005_bb0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/art.20056","article-title":"PM-Scl-75 is the main autoantigen in patients with the polymyositis\/scleroderma overlap syndrome","volume":"50","author":"Raijmakers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0240","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0245","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.110071","article-title":"Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis","volume":"38","author":"Sharif","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0250","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.2476849","article-title":"The RNA processing enzyme RNase MRP is identical to the Th RNP and related to RNase P","volume":"245","author":"Gold","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.autrev.2012.07.005_bb0255","first-page":"2454","article-title":"Influence of clinical features, serum antinuclear antibodies, and lung functions on survival of patients with systemic sclerosis","volume":"28","author":"Jacobsen","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0260","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3899\/jrheum.100316","article-title":"Anti-Th\/To are common antinucleolar autoantibodies in Italian patients with scleroderma","volume":"37","author":"Ceribelli","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0265","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3899\/jrheum.100754","article-title":"Antinuclear antibodies and clinical associations in a British Cohort with limited cutaneous systemic sclerosis","volume":"38","author":"Gliddon","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0270","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2010.05.020","article-title":"Anti-Ku: clinical, genetic and diagnostic insights","volume":"9","author":"Belizna","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0275","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/ard.2007.073981","article-title":"Prevalence and clinical association of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case\u2013control study","volume":"67","author":"Rozman","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.07.005_bb0280","first-page":"1543","article-title":"Autoantibodies to NOR 90\/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response","volume":"29","author":"Dagher","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.005_bb0285","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.autrev.2012.07.005_bb0290","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","article-title":"Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis","volume":"60","author":"Classen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0295","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","article-title":"Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera","volume":"60","author":"Loizos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.005_bb0300","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/ard.2007.085480","article-title":"Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis","volume":"67","author":"Balada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.07.005_bb0305","first-page":"458","article-title":"Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus","volume":"20","author":"Kurasawa","year":"2010","journal-title":"Mol Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T16:04:05Z","timestamp":1642694645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1568997212001292"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.07.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}